PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment.

Last updated on 23-5-2024 by Marie Malingreau

Public Access

Published

Peer reviewed scientific article

Anglais

SCIENSANO

Résumé:

PRECISION is an initiative from the Belgian Society of Medical Oncology (BSMO) in collaboration with several stakeholders, encompassing four programs that aim to boost genomic and clinical knowledge with the ultimate goal to offer patients with metastatic solid tumors molecularly guided treatments. The PRECISION 1 study has led to the creation of a clinico-genomic database. The Belgian Approach for Local Laboratory Extensive Tumor Testing (BALLETT) and GeNeo studies will increase the number of patients with advanced cancer that have comprehensive genotyping of their cancer. The PRECISION 2 …

Associated health topics:

QR code

QR code for this page URL